Concepedia

Susan Lattimore

SL

14

Publications

873

Citations

12

H-Index

2003

Active since

Affiliations

Oregon Health & Science University(Current)

University of Michigan

University of North Carolina at Chapel Hill

Erasmus MC

University Hospital Frankfurt

Susan Lattimore is an author at Oregon Health & Science University specializing in medicine, hematology, and patient safety.

ORCID

Top concepts

Publications per year

2003–2025

14

Publications

14

Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B

Steven W. Pipe, Frank W.G. Leebeek, Michael Recht et al. · New England Journal of Medicine · 2023 · 307 citations · Full text

Etranacogene dezaparvovec (AMT-061 phase 2b): normal/near normal FIX activity and bleed cessation in hemophilia B

Annette von Drygalski, Adam Giermasz, Giancarlo Castaman et al. · Blood Advances · 2019 · 124 citations · Full text

Impact of Establishing a Primary Stroke Center at a Community Hospital on the Use of Thrombolytic Therapy

Susan Lattimore, Julio A. Chalela, Lisa Davis et al. · Stroke · 2003 · 107 citations · Full text

Assessment of neonatal platelet adhesion, activation, and aggregation

Sandra M. Baker-Groberg, Susan Lattimore, Michael Recht et al. · Journal of Thrombosis and Haemostasis · 2016 · 56 citations · Full text

, , +6

Stable and durable factor IX levels in patients with hemophilia B over 3 years after etranacogene dezaparvovec gene therapy

Annette von Drygalski, Esteban Moreno Gómez, Adam Giermasz et al. · Blood Advances · 2022 · 56 citations · Full text

, , +19

Rows per page

1–5 of 14